Trial intelligence / Profile preview

Voluven Effect on Renal Function in Radical Prostatectomy

NCT01486563Phase 4Completed

Sponsor
Regionshospitalet Holstebro
Start
Jan 2012
Primary completion
Jun 2013
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Volulyte in prostate cancer (PCa), sponsored by Regionshospitalet Holstebro. Started Jan 2012; status: completed.

02

Drugs

Volulyte
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT01486563.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01486563.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call